Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
The state of New York is suing a major pharmaceuticals company alleging widespread fraud and deceptive marketing of opioids that have contributed to a national epidemic.
An artificial intelligence (AI) system designed by Google's DeepMind and London researchers can diagnose eye disease as accurately as some experts, according to a report by the BBC.
In another sign that technology companies are increasingly looking for ways to build out their businesses in the healthcare sector, Amazon, Microsoft, Google, IBM, Oracle and Salesforce have teamed up to address healthcare interoperability.
Alyssa Gilderhus was 18 when she suffered a brain aneurysm and entered Mayo Clinic in Rochester, Minnesota. Surgeons saved her life, but her parents were dissatisfied with her care in the rehabilitation unit and wanted her transferred.
A protein molecule in the blood could indicate whether a person will develop kidney cancer, according to a study published in Clinical Cancer Research.
When CMS announced it was changing the accountable care organization model to encourage more organizations to take on more financial risk, industry stakeholders had a lot to review in the 600-plus page proposed rule.
The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.
